查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586180

细胞裂解/细胞分馏市场：按产品类型、细胞类型、应用和最终用户 - 2025-2030 年全球预测

Cell Lysis/Cell Fractionation Market by Product (Consumables, Instruments), Cell Type (Mammalian Cells, Microbial Cells), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

细胞裂解/细胞分化市场2023年估值为33.5亿美元，预计2024年将达到36.3亿美元，复合年增长率为8.55%，到2030年将达到59.5亿美元，预计将达到1000万美元。

细胞裂解和细胞分级分离是分子生物学和生物化学中的重要技术，对于分离细胞成分以进行进一步分析至关重要。这些过程使科学家能够破坏细胞（裂解）并分离其内部成分（分级分离），从而更容易研究蛋白质、核酸和其他分子。这些技术的需求源于它们在研究、医学和诊断中的广泛应用，从而促进了疾病理解、药物开发和治疗方法的进步。最终用途范围广泛，包括生物技术公司、研究实验室、临床应用以及专注于个人化医疗和基因组学的行业。市场成长受到研发投资增加、设备技术进步以及需要新疗法的慢性病盛行率上升的影响。开发自动化、易于使用的设备以提高细胞分析的准确性和效率的机会比比皆是。人工智慧和机器学习在资料分析中的整合提供了一个充满希望的前沿领域，探索更温和的细胞裂解以保护脆弱的生物分子的新技术也是如此。然而，该市场面临一些限制，例如高营运成本以及维持细胞完整性和污染风险的技术挑战。生物技术领域的智慧财产权问题和严格的监管标准进一步增加了障碍。抓住机会的建议包括投资于降低製程复杂性和成本的创新，并专注于方法和材料的永续性。学术机构和生物技术公司之间的合作伙伴关係可以加速新方法的整合。创新也应着重于小型化和实验室晶片技术，以解决资源有限环境中日益有价值的护理点应用问题。总体而言，这个市场被视为充满活力但充满挑战，对于那些策略性地驾驭其复杂性的人来说具有巨大的潜力。

主要市场统计
基准年[2023] 33.5亿美元
预测年份 [2024] 36.3亿美元
预测年份 [2030] 59.5亿美元
复合年增长率（%） 8.55%

市场动态：快速发展的细胞裂解/细胞分级市场的关键市场洞察

细胞裂解/细胞分馏市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 医疗保健、生命科学和製药业的扩张
    • 增加政府对生命科学研究的资助
    • 爱滋病毒/爱滋病和癌症等疾病的流行不断扩大
  • 市场限制因素
    • 细胞设备和研究成本上升
  • 市场机会
    • 对个人化医疗以及生物製药和生物技术行业扩张的兴趣日益浓厚
    • 医疗机构积极的研究活动
  • 市场挑战
    • 缺乏受过训练的细胞裂解/细胞分级人员

波特的五力：驾驭细胞裂解/细胞分级分离市场的策略工具

波特的五力架构是了解细胞裂解/细胞分级市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解细胞裂解/细胞分馏市场的外部影响

外部宏观环境因素在塑造细胞裂解/细胞分馏市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解细胞裂解/细胞分馏市场的竞争格局

细胞裂解/细胞分级市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV定位矩阵细胞裂解/细胞分馏市场供应商的绩效评估

FPNV定位矩阵是评估细胞裂解/细胞分馏市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了细胞裂解/细胞分级市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对细胞裂解/细胞分级市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大医疗保健、生命科学和製药业
      • 增加政府对生命科学研究的资助
      • 爱滋病毒/爱滋病和癌症等疾病的盛行率增加
    • 抑制因素
      • 基于细胞的设备和研究高成本
    • 机会
      • 日益关注个人化医疗以及生物製药和生物技术产业的扩张
      • 跨医疗机构强大的细胞裂解/细胞分级研究活动
    • 任务
      • 缺乏受过训练的细胞裂解/细胞分级人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章细胞裂解/细胞分馏市场：副产品

  • 消耗品
    • 珠
    • 一次性的
    • 试剂和套件
  • 装置
    • 均质器
    • 超音波仪

第 7 章按细胞类型分類的细胞裂解/细胞分馏市场

  • 哺乳动物细胞
  • 微生物细胞

第 8 章 细胞裂解/细胞分馏市场：依应用分类

  • 核酸精製与分离
  • 蛋白质精製与分离

第 9 章 细胞裂解/细胞分馏市场：依最终用户分类

  • 生物製药和生物技术公司
  • 研究室/实验室

第10章美洲细胞裂解/细胞分馏市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太细胞裂解/细胞分馏市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的细胞裂解/细胞分馏市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abcam PLC
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Claremont BioSolutions, LLC
  • Covaris, LLC
  • Creative Biostructure
  • F. Hoffmann-La Roche Ltd.
  • Geno Technology Inc.
  • Invent Biotechnologies, Inc.
  • Merck KGaA
  • Microfluidics International Corporation by IDEX Corporation
  • Miltenyi Biotec BV & Co. KG
  • Norgen Biotek Corp.
  • NZYTech, Lda.
  • Parr Instrument Company
  • Promega Corporation
  • PromoCell GmbH
  • Qiagen NV
  • Qsonica LLC
  • STEMCELL Technologies Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-FD3F12D5351C

The Cell Lysis/Cell Fractionation Market was valued at USD 3.35 billion in 2023, expected to reach USD 3.63 billion in 2024, and is projected to grow at a CAGR of 8.55%, to USD 5.95 billion by 2030.

Cell lysis and cell fractionation are vital techniques in molecular biology and biochemistry, essential for isolating cellular components for further analysis. These processes allow scientists to break open cells (lysis) and separate their internal constituents (fractionation), thereby facilitating the study of proteins, nucleic acids, and other molecules. The necessity of these techniques arises from their widespread application in research, pharmaceuticals, and diagnostics, enabling advancements in disease understanding, drug development, and therapeutic solutions. The end-use scope is expansive, spanning biotechnology firms, research labs, clinical applications, and industries focused on personalized medicine and genomics. Market growth is influenced by increased R&D investments, technological advancements in equipment, and the rising prevalence of chronic diseases necessitating novel treatments. Opportunities abound in developing automated, user-friendly equipment that enhances precision and efficiency in cell analysis. The integration of AI and machine learning for data analysis presents a promising frontier, as does exploring novel techniques for gentler cell lysis to protect fragile biomolecules. However, the market faces limitations such as high operational costs and technical challenges related to preserving cell integrity and the risk of contamination. Intellectual property issues and strict regulatory standards in biotechnology add further hurdles. Recommendations for seizing opportunities include investing in innovations that reduce process complexity and cost, and emphasizing sustainability in methods and materials. Collaborative partnerships between academic institutions and biotech firms can accelerate the integration of new methods. Innovations should also focus on miniaturization and lab-on-a-chip technologies to cater to point-of-care applications, which are increasingly valuable in resource-limited settings. Overall, the market is seen as dynamic but challenging, with significant potential for those who navigate its complexities strategically.

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.63 billion
Forecast Year [2030] USD 5.95 billion
CAGR (%) 8.55%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Lysis/Cell Fractionation Market

The Cell Lysis/Cell Fractionation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expanding healthcare, life sciences, and pharmaceutical industries
    • Increasing government funding for research in life sciences
    • Growing prevalence of diseases such as HIV/AIDS and cancer
  • Market Restraints
    • High cost of cell-based equipment and research
  • Market Opportunities
    • Growing focus on personalized medicine and the expansion of biopharmaceutical and biotechnology industries
    • Robust cell lysis/cell fractionation research activities across medical institutes
  • Market Challenges
    • Shortage of trained personnel for cell lysis/cell fractionation

Porter's Five Forces: A Strategic Tool for Navigating the Cell Lysis/Cell Fractionation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Lysis/Cell Fractionation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Lysis/Cell Fractionation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Lysis/Cell Fractionation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Lysis/Cell Fractionation Market

A detailed market share analysis in the Cell Lysis/Cell Fractionation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Lysis/Cell Fractionation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Lysis/Cell Fractionation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Lysis/Cell Fractionation Market

A strategic analysis of the Cell Lysis/Cell Fractionation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Lysis/Cell Fractionation Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agilent Technologies, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Claremont BioSolutions, LLC, Covaris, LLC, Creative Biostructure, F. Hoffmann-La Roche Ltd., Geno Technology Inc., Invent Biotechnologies, Inc., Merck KGaA, Microfluidics International Corporation by IDEX Corporation, Miltenyi Biotec B.V. & Co. KG, Norgen Biotek Corp., NZYTech, Lda., Parr Instrument Company, Promega Corporation, PromoCell GmbH, Qiagen NV, Qsonica L.L.C, STEMCELL Technologies Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Lysis/Cell Fractionation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Beads, Disposables, and Reagents & Kits. The Instruments is further studied across Homogenizers and Sonicators.
  • Based on Cell Type, market is studied across Mammalian Cells and Microbial Cells.
  • Based on Application, market is studied across Nucleic Acid Purification & Isolation and Protein Purification & Isolation.
  • Based on End-User, market is studied across Biopharmaceutical & Biotechnology Companies and Research Laboratories & Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries
      • 5.1.1.2. Increasing government funding for research in life sciences
      • 5.1.1.3. Growing prevalence of diseases such as HIV/AIDS and cancer
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cell-based equipment and research
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on personalized medicine and the expansion of biopharmaceutical and biotechnology industries
      • 5.1.3.2. Robust cell lysis/cell fractionation research activities across medical institutes
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of trained personnel for cell lysis/cell fractionation
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Lysis/Cell Fractionation Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Beads
    • 6.2.2. Disposables
    • 6.2.3. Reagents & Kits
  • 6.3. Instruments
    • 6.3.1. Homogenizers
    • 6.3.2. Sonicators

7. Cell Lysis/Cell Fractionation Market, by Cell Type

  • 7.1. Introduction
  • 7.2. Mammalian Cells
  • 7.3. Microbial Cells

8. Cell Lysis/Cell Fractionation Market, by Application

  • 8.1. Introduction
  • 8.2. Nucleic Acid Purification & Isolation
  • 8.3. Protein Purification & Isolation

9. Cell Lysis/Cell Fractionation Market, by End-User

  • 9.1. Introduction
  • 9.2. Biopharmaceutical & Biotechnology Companies
  • 9.3. Research Laboratories & Institutes

10. Americas Cell Lysis/Cell Fractionation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Lysis/Cell Fractionation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Lysis/Cell Fractionation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Agilent Technologies, Inc.
  • 3. Beckman Coulter, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Cell Signaling Technology, Inc.
  • 7. Claremont BioSolutions, LLC
  • 8. Covaris, LLC
  • 9. Creative Biostructure
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Geno Technology Inc.
  • 12. Invent Biotechnologies, Inc.
  • 13. Merck KGaA
  • 14. Microfluidics International Corporation by IDEX Corporation
  • 15. Miltenyi Biotec B.V. & Co. KG
  • 16. Norgen Biotek Corp.
  • 17. NZYTech, Lda.
  • 18. Parr Instrument Company
  • 19. Promega Corporation
  • 20. PromoCell GmbH
  • 21. Qiagen NV
  • 22. Qsonica L.L.C
  • 23. STEMCELL Technologies Inc.
  • 24. Takara Bio Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. CELL LYSIS/CELL FRACTIONATION MARKET RESEARCH PROCESS
  • FIGURE 2. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CELL LYSIS/CELL FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL LYSIS/CELL FRACTIONATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL LYSIS/CELL FRACTIONATION MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 150. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 277. CELL LYSIS/CELL FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023